226
Participants
Start Date
April 21, 2008
Primary Completion Date
September 16, 2010
Study Completion Date
September 16, 2010
Rosiglitazone
up to 8mg/day
Metformin
up to 2000mg/day
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Marikina City
GSK Investigational Site, Kingston
GSK Investigational Site, East Syracuse
GSK Investigational Site, Tallinn
GSK Investigational Site, Tallinn
GSK Investigational Site, Granada
GSK Investigational Site, Granada
GSK Investigational Site, Columbia
GSK Investigational Site, Columbia
GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Durango
GSK Investigational Site, Kingsport
GSK Investigational Site, Lexington
GSK Investigational Site, Lahore
GSK Investigational Site, Cuernavaca
GSK Investigational Site, Monterrey
GSK Investigational Site, Slidell
GSK Investigational Site, San Antonio
GSK Investigational Site, Tucson
GSK Investigational Site, Albuquerque
GSK Investigational Site, Albuquerque
GSK Investigational Site, Las Vegas
GSK Investigational Site, Los Angeles
GSK Investigational Site, Huntington Park
GSK Investigational Site, Torrance
GSK Investigational Site, Vista
GSK Investigational Site, San Diego
GSK Investigational Site, Sacramento
GSK Investigational Site, Mérida
GSK Investigational Site, Wenatchee
GSK Investigational Site, Ciudad Autonoma de Buenos Aires
GSK Investigational Site, Ciudad Autonoma de Buenos Aires
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Vancouver
GSK Investigational Site, Brampton
GSK Investigational Site, Granby
GSK Investigational Site, Manila
GSK Investigational Site, Alicante
GSK Investigational Site, Benidorm/Alicante
GSK Investigational Site, Petrel
Lead Sponsor
GlaxoSmithKline
INDUSTRY